Sort
261,768 grants matching “gene therapy”
XoLacta: An Adjuvant Therapy for treatment of Radiation Side effects during HER2-Positive Breast Cancer Treatment
$1,022,907Spencer Reid Marsh · Tiny Cargo Company, The · R44 · FY2025 · CA
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,022,875Kuan Wang · National Institute Of Mental Health · ZIA · FY2013 · MH
Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion
$1,022,830Brian Robert Krause · Alphacore Pharma, Llc · R44 · FY2010 · HL
Natural History of Familial Carcinoid Tumor
$1,022,820Stephen Wank · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Retinal Gene Therapy
$1,022,735Peter Colosi · National Eye Institute · ZIA · FY2012 · EY
Neurogenetic Processes in the Fetal Brain
$1,022,669Pasko Rakic · Yale University · R01 · FY2012 · NS
Discovery and therapeutic targeting non-coding RNAs in T1D- or T2D-associated atherosclerosis
$1,022,611Mark W Feinberg · Brigham And Women'S Hospital · U01 · FY2024 · DK
Discovery and therapeutic targeting non-coding RNAs in T1D- or T2D-associated atherosclerosis
$1,022,611Mark W Feinberg · Brigham And Women'S Hospital · U01 · FY2025 · DK
Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate Cancer
$1,022,522Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2025 · CA
Molecular Pathogenesis of Neoplasia
$1,022,497Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,022,419Stuart H. Yuspa · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
A NOVEL NEUROPROTECTIVE THERAPY FOR ALZHEIMERâS DISEASE
$1,022,134Menachem Abraham · Klogene Therapeutics, Inc. · R44 · FY2016 · AG
Stalled replication fork repair in cancer predisposition and cancertherapy
$1,022,022Ralph Scully · Beth Israel Deaconess Medical Center · R35 · FY2022 · CA
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$1,021,968Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Pathway and GWAS SNPs: Role in SCCHN Risk, Outcome and Treatment Response
$1,021,889Brenda Diergaarde · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · CA
Novel Small-Molecule Therapies for CF
$1,021,850Alan S Verkman · University Of California, San Francisco · P30 · FY2016 · DK
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,021,774Thomas R Hawn · University Of Washington · R33 · FY2020 · AI
Molecular Therapy Core Center
$1,021,750University Of North Carolina Chapel Hill · P30 · FY2005 · DK
Elucidating microvascular contributions to cognitive impairment at single-cell resolution
$1,021,590Andrew Chris Yang · University Of California, San Francisco · R01 · FY2022 · NS
Inhibition of hepatitis C by RNA-based therapeutics
$1,021,558Brian H. Johnston · Somagenics, Inc. · R44 · FY2007 · AI
Lymphoma Disease Discovery and Definition
$1,021,536Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
A Haplotype Map for Multiple Sclerosis
$1,021,472Stephen L Hauser · University Of California, San Francisco · R01 · FY2014 · NS
Novel Insights Into Cerebral Ischemic Pathophysiology In Humans
$1,021,461Lawrence Latour · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Clinical Research on Nonalcoholic Fatty Liver Disease
$1,021,433Joel Edward Lavine · Columbia University Health Sciences · U01 · FY2011 · DK
Combined cytokine therapy for sustained HIV remission
$1,021,416Vijayakumar Velu · Emory University · R01 · FY2023 · AI